The Little Giants

Behind China’s flagship manufacturers sits a quieter industrial-policy machine aimed at the parts that make them possible. The “little giant” (xiao juren) designation, part of the broader 专精特新, “specialised, refined, differentiated, innovative”, program, marks out elite small and medium manufacturers that dominate a narrow niche with advanced technology. It is, deliberately, China’s answer to Germany’s Mittelstand of hidden champions.

The scale is now substantial. By November 2025 China had designated more than 17,600 national-level little giants, up from around 5,000 at the start of the current five-year plan in 2021.^[1] Their economic weight is disproportionate to their number: little giants are about 3.5% of China’s above-scale industrial SMEs yet generate some 9.6% of that sector’s revenue and 13.7% of its profits.^[2] The strategic intent is explicit, roughly three-quarters operate in Made in China 2025 priority sectors, and a large share cite domestic substitution directly, targeting the “chokepoint” components in semiconductors, robotics, medical devices and aerospace that sanctions expose.^[2][3]

3.5% of China’s industrial SMEs throw off 13.7% of the sector’s profits, and the state has fielded 17,600 of them to plug the gaps a rival could choke.

The state as venture capitalist

The program comes with capital to match the designation: direct municipal subsidies, preferential lending, and a dedicated public market, the Beijing Stock Exchange, launched in 2021 with flexible listing rules explicitly to fund these firms, which made up around 40% of mainland listings in 2022.^[3] The honest caveats are equally documented. Selection is uneven, with some designated firms falling short of the standard; there is a real risk of subsidy dependence; and analysis has found that little giants with government-linked investors tend to underperform their more private peers — a reminder that a state stamp is not the same as a market winner.^[3]

The bottom line for capital

The little-giant program is the single best map China’s government has published of where it believes its supply chain is vulnerable, a curated list of the niche components it most wants to localise, backed by real capital and a listing venue. For an investor that list is a genuine source of edge, pointing toward categories with structural policy demand behind them. The discipline is to use it as a starting screen, not a buy list: the designation signals strategic priority and access to support, not commercial quality, and the evidence that state-linked backing can dull performance is a caution to underwrite the business, not the badge.